The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Weekly nab-paclitaxel (nab-P) plus gemcitabine (gem) or carboplatin (carbo) vs gem/carbo as first-line treatment for metastatic triple-negative breast cancer (mTNBC) in a phase 2/3 trial (tnAcity).
 
Denise A. Yardley
Consulting or Advisory Role - Celgene
 
Javier Cortes
Honoraria - Celgene; Eisai; Novartis; Roche Pharma AG
Consulting or Advisory Role - Celgene; Roche Pharma AG
 
Robert E. Coleman
Expert Testimony - Novartis
 
Pier Franco Conte
No Relationships to Disclose
 
Adam Brufsky
Consulting or Advisory Role - Celgene
 
Joyce O'Shaughnessy
Honoraria - Celgene
Consulting or Advisory Role - Celgene
 
Gail Lynn Shaw Wright
Honoraria - Myriad Genetics
Speakers' Bureau - Myriad Genetics
 
Janice F. Eakle
No Relationships to Disclose
 
Sharon Wilks
Honoraria - Genentech
Speakers' Bureau - Genentech
 
Mikhail Shtivelband
No Relationships to Disclose
 
Robyn R. Young
Employment - Center for Cancer and Blood Disorders
Speakers' Bureau - Genentech
Travel, Accommodations, Expenses - Astellas Pharma; Incyte; Novartis; Sarah Cannon Research Institute
 
Carmelo Bengala
No Relationships to Disclose
 
Huiling Li
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene
 
Julie Ann Miller
Employment - Celgene
Stock and Other Ownership Interests - Celgene; Celgene (I)
 
Debora Barton
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Nadia Harbeck
Honoraria - Amgen; Celgene; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Celgene; Genomic Health; Novartis; Roche/Genentech; Sandoz; Wilex
Research Funding - Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)